Clinical trials
Acute Chest Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 4 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Recruiting | 7 |
| Terminated | 6 |
| Not yet recruiting | 4 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 11 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| Albert Einstein College of Medicine | 1 |
| Alexhander Izhaki | 1 |
| Anthera Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Carelon Research | 1 |
| Centre Hospitalier Intercommunal Creteil | 1 |
| Centre Hospitalier de Saint-Denis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Chest Syndrome | 40 |
| Anemia, Sickle Cell | 34 |
| Vaso-Occlusive Crises | 11 |
| Asthma | 3 |
| Hypertension, Pulmonary | 3 |
| Respiratory Tract Infections | 2 |
| Vitamin D Deficiency | 2 |
| Acute Kidney Injury | 1 |
| Acute Lung Injury | 1 |
| Agnosia | 1 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.